Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study of the Safety and Efficacy of Combination Therapy With AVONEX and Bi-Monthly High Dose Intravenous Methotrexate With Leucovorin Rescue in the Treatment of Multiple Sclerosis

NCT00037102 is registered in ClinicalTrials.gov with MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute as lead sponsor.

NCT NCT00037102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00037102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study of the Safety and Efficacy of Combination Therapy With AVONEX and Bi-Monthly High Dose Intravenous Methotrexate With Leucovorin Rescue in the Treatment of Multiple Sclerosis
Lead sponsor
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2001
Completion date
December 31, 2003
Enrollment
16 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis